Clinical Trials Browser

Phase 2 × Vulvar Neoplasms × antineoplaston AS 2-1 × Clear all

NCT00003525 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva

Phase 2 Terminated

Uterine Cervical Neoplasms, Vulvar Neoplasms